Precision Medicine

• Genetics and genomics study of endocrine disorders.
• Using integrative omics to develop new drugs and health supplement.
• Development of novel biomarker or prediction score for predicting clinical outcomes, such as incident disease, mortality, and treatment effectiveness (in endocrine disorders and cancer).
• Evaluation of the effectiveness and safety of health supplement using randomized controlled trial, metabolomics, and animal study.
• Pharmacogenomics of serious drug-related adverse events and treatment effectiveness.